Short Interest in SeaStar Medical Holding Co. (NASDAQ:ICU) Expands By 53.3%

SeaStar Medical Holding Co. (NASDAQ:ICU) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 518,200 shares, an increase of 53.3% from the November 30th total of 338,100 shares. Based on an average daily volume of 203,700 shares, the short-interest ratio is currently 2.5 days. Approximately 12.1% of the company’s stock are short sold.

SeaStar Medical Price Performance

Shares of SeaStar Medical stock opened at $2.04 on Monday. SeaStar Medical has a 1-year low of $1.69 and a 1-year high of $42.92. The business has a 50-day moving average of $2.52 and a 200-day moving average of $4.89. The company has a market capitalization of $9.10 million, a PE ratio of -0.18 and a beta of -1.13.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.